Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Debt Ratio: 2011-2025

Historic Debt Ratio for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to 0.51.

  • Lifecore Biomedical's Debt Ratio rose 26.59% to 0.51 in Q2 2025 from the same period last year, while for May 2025 it was 0.51, marking a year-over-year increase of 26.59%. This contributed to the annual value of 0.51 for FY2025, which is 26.59% up from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical's Debt Ratio is 0.51, which was up 4.06% from 0.49 recorded in Q1 2025.
  • Lifecore Biomedical's Debt Ratio's 5-year high stood at 0.51 during Q2 2025, with a 5-year trough of 0.33 in Q2 2023.
  • Its 3-year average for Debt Ratio is 0.41, with a median of 0.41 in 2023.
  • Per our database at Business Quant, Lifecore Biomedical's Debt Ratio plummeted by 36.57% in 2021 and then increased by 26.59% in 2025.
  • Over the past 5 years, Lifecore Biomedical's Debt Ratio (Quarterly) stood at 0.39 in 2021, then dropped by 9.10% to 0.36 in 2022, then grew by 5.35% to 0.38 in 2023, then grew by 15.37% to 0.44 in 2024, then increased by 26.59% to 0.51 in 2025.
  • Its Debt Ratio was 0.51 in Q2 2025, compared to 0.49 in Q1 2025 and 0.44 in Q4 2024.